Η CURIUM ΑΝΑΚΟΙΝΏΝΕΙ ΌΤΙ ΟΙ ΠΡΏΤΟΙ ΑΣΘΕΝΕΊΣ ΣΤΗΝ ΕΛΛΆΔΑ ΈΛΑΒΑΝ ΈΝΕΣΗ ΜΕ PYLCLARI® - ΈΝΑΝ ΚΑΙΝΟΤΌΜΟ ΙΧΝΗΘΈΤΗ PET 18F-PSMA ΠΟΥ ΕΝΔΕΊΚΝΥΤΑΙ ΣΕ ΑΣΘΕΝΕΊΣ ΜΕ ΚΑΡΚΊΝΟ ΤΟΥ ΠΡΟΣΤΆΤΗ
November 16, 2023 05:14 ET
|
Curium US LLC
ΠΑΡΙΣΙ, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Η Curium, παγκόσμιος ηγέτης στην πυρηνική ιατρική, ανακοίνωσε σήμερα ότι σε συνεργασία με τον αποκλειστικό διανομέα της SYN Innovation Laboratories στην...
Curium Announces First Patients in Europe Injected With PYLCLARI® – an Innovative 18F-PSMA Pet Tracer Indicated in Patients With Prostate Cancer
November 16, 2023 05:14 ET
|
Curium
PARIS, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that in partnership with its exclusive distributor SYN Innovation Laboratories in Greece, the...
Blackford and AIQ Solutions Announce Commercial Partnership to Bring Advanced Clinical Decision Support Tools for Metastatic Cancer to Healthcare Providers
November 14, 2023 09:00 ET
|
Blackford
Blackford and AIQ Solutions Announce Commercial Partnership to Bring Advanced Clinical Decision Support Tools for Metastatic Cancer to Healthcare Providers
Nuclear Medicine Market To Reach USD 46.3 Billion By 2032 Report By DataHorizzon Research
October 27, 2023 08:10 ET
|
DataHorizzon Research
Fort Collins, Colorado, Oct. 27, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the Nuclear Medicine Market size was valued at USD 8.1 Billion in 2022 and is expected to reach USD 46.3...
CURIUM UND PIUR IMAGING KÜNDIGEN EINE PARTNERSCHAFT FÜR DIE SCHILDDRÜSENBILDGEBUNG IN DEUTSCHLAND AN, UM TOMOGRAPHISCHE 3D-ULTRASCHALLÖSUNGEN ZU ERMÖGLICHEN
October 25, 2023 07:33 ET
|
Curium
BERLIN, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Curium, ein weltweit führendes Unternehmen in der Nuklearmedizin, und PIUR IMAGING, ein europäisches Medizintechnikunternehmen, das bei der Entwicklung von...
Curium and PIUR IMAGING Announce Thyroid Imaging Partnership in Germany to Enable Tomographic 3D Ultrasound Solutions
October 25, 2023 07:33 ET
|
Curium
BERLIN, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, and PIUR IMAGING, a European medical device company at the forefront of pioneering tomographic 3D ultrasound...
Non-Invasive Cancer Diagnostics Market Size & Share Surpass USD 207 billion by 2031, Growing at a CAGR of 7.0% - Exclusive Study by Transparency Market Research
October 19, 2023 11:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global non-invasive cancer diagnostics market is projected to flourish at a CAGR of 7.0%...
Global Radiopharmaceuticals Strategic Analysis Report 2023: Market to Reach $14.3 Billion by 2030 - Emergence of Radiotheranostics as Dual-Functioning Radiopharmaceuticals Bolsters Growth
October 09, 2023 05:48 ET
|
Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Radiopharmaceuticals Market...
Nuclear Medicine Market to Hit USD 25 Mn | Innovations and Insights into Diagnostic Advancements (2023-2032)
September 15, 2023 06:25 ET
|
Market.Us
New York, Sept. 15, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Nuclear Medicine Market size is expected to be worth around USD 25 Million by 2032 from USD 7.0...
Curium Announces Exclusive Distribution Agreement in Switzerland with b.e. Imaging for PYLCLARI™, an Innovative 18F-PSMA Pet Tracer Indicated in Adults with Prostate Cancer
September 07, 2023 04:25 ET
|
Curium
PARIS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has entered into an exclusive rights agreement with b.e. Imaging, for the distribution...